Fortify Software

KBRA Assigns Preliminary Ratings to FortiFi 2023-1, Series 2023-1

Retrieved on: 
Wednesday, May 17, 2023
Banking, Professional Services, Finance, KBRA, PACE, Initial, Fortify Software, Semiconductor, Telescopic sight

KBRA assigns preliminary ratings to two classes of notes issued by FortiFi 2023-1, Series 2023-1 (“FortiFi 2023-1”, LLC.

Key Points: 
  • KBRA assigns preliminary ratings to two classes of notes issued by FortiFi 2023-1, Series 2023-1 (“FortiFi 2023-1”, LLC.
  • The notes are newly issued asset-backed securities backed by a portfolio of Property Assessed Clean Energy (“PACE”) Bonds.
  • The Class A Notes and Class B Notes (together, the “Notes”) are secured by a portfolio of PACE bonds (“PACE Bonds”) acquired by FortiFi 2023-1 (the “Issuer”) at closing (the “Initial PACE Bonds”) and during the Prefunding Period (the “Subsequent PACE Bonds” and together with the Initial PACE Bonds, the “PACE Bond Portfolio”).
  • The Initial PACE Bonds are secured by 5,025 PACE assessments levied against 5,007 residential properties and 18 commercial properties (“PACE Assessments”) in 41 Florida counties and 33 California counties.

Bolster Appoints Key Customer Success and People Executives as Customer Adoption Grows Over 200% in 12 Months

Retrieved on: 
Tuesday, March 28, 2023
Workforce, Fortify Software, Customer success, AT&T Cybersecurity, Booking.com, Contrast, Canon Inc., Bolster, Culture, Uber, Woman, Organization, Internet, LOS, Coinbase, Management, Online shopping, Covanta

LOS ALTOS, Calif., March 28, 2023 /PRNewswire/ -- Bolster Inc., the automated digital risk protection company, today announced two key executive hires to support significant customer adoption and company growth. Jack Marshall joins as Vice President of Customer Success and will be responsible for supporting the company's accelerated rate of customer growth. Cleo Valeroso joins as Vice President of People and will be responsible for an aggressive hiring strategy and continuing Bolster's important cultural initiatives.

Key Points: 
  • Jack Marshall joins as Vice President of Customer Success and will be responsible for supporting the company's accelerated rate of customer growth.
  • "I'm so pleased to welcome Jack and Cleo to our team," stated Abhishek Dubey, co-founder and CEO of Bolster.
  • Customer success and culture have always been top priorities for Bolster and I'm thrilled to have two industry leaders join our team to continue our mission.
  • "Throughout my career, I've had the great fortune of developing robust customer success organizations for fast growing companies," stated Marshall.

Prolacta Clinical Advisory Board Members Present Webinar on Improved Growth Metrics for Preterm Infants Fed an Exclusive Human Milk Diet

Retrieved on: 
Thursday, December 1, 2022
Growth, Fortify Software, NICU, Lactoferrin, UHT, MS, Infection, Antibody, Necrosis, Late preterm infant, Food, Biological activity, NPAC, Milk, Nutritional science, Risk, Safety, Knowledge, Patient, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, LD, Education, NAC, Pasteurization, RDN, CNSC, Jean-Louis Vincent, Research, Health, Immunity, Science, Infant, Health maintenance organization, FDA Adverse Event Reporting System, FDA, Sepsis, Medicine

DUARTE, Calif., Dec. 1, 2022 /PRNewswire/ -- Prolacta Bioscience®, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill, premature infants, announced today that two members of the Prolacta Clinical Advisory Board (PCAB) will present a webinar for clinicians who care for preterm infants titled "Improved Growth Metrics for Preterm Infants Supported With a Human Milk Diet" on Thursday, Dec. 1, at 9 a.m. PT.

Key Points: 
  • Stacia Pegram, MA, RDN, LD, and Patti Perks, MS, RDN, CNSC, will present "Improved Growth Metrics for Preterm Infants Supported With a Human Milk Diet" on Dec. 1
    DUARTE, Calif., Dec. 1, 2022 /PRNewswire/ -- Prolacta Bioscience , the world's leading hospital provider of 100% human milk-based nutritional products for critically ill, premature infants, announced today that two members of the Prolacta Clinical Advisory Board (PCAB) will present a webinar for clinicians who care for preterm infants titled "Improved Growth Metrics for Preterm Infants Supported With a Human Milk Diet" on Thursday, Dec. 1, at 9 a.m. PT.
  • Perks and Pegram are members of the Prolacta Clinical Advisory Board (PCAB), a group of neonatologists, neonatal nursing leaders, and neonatal dietitians with broadly recognized clinical expertise.
  • Prolacta's 100% human milk-based nutritional products have been evaluated in more than 20 clinical studies published in peer-reviewed journals.
  • Prolacta maintains the industry's strictest quality and safety standards for screening, testing, and processing donor human milk.

Shield Capital Announces Venture Partners Michael A. Brown and John “JJ” Jack

Retrieved on: 
Tuesday, October 18, 2022
Technology, Other Defense, Finance, Venture Capital, Security, Professional Services, Software, Internet, Defense, Artificial Intelligence, SHIELD, Philip Bilden, PeopleSoft, Committee on Foreign Investment in the United States, Norwest Venture Partners, DIU, NortonLifeLock, Intelligence, COO, Mentorship, Fortify Software, Sybase, Technology, Artificial intelligence, Capital, Vantive, Marketing, Defense Innovation Unit, Industry, Quantum Corporation, Foreign investment, Committee, CEO, Ecosystem, Board, JJ, Presidential Innovation Fellows, Board of directors, Hewlett-Packard, CFIUS, VMware, Management, Covalent bond

Brown and John JJ Jack have joined Shield Capital as Venture Partners.

Key Points: 
  • Brown and John JJ Jack have joined Shield Capital as Venture Partners.
  • We are honored that these distinguished leaders will partner with SHIELD in our mission, noted Philip Bilden, Managing Partner.
  • Michael Brown and John Jack have built and scaled market-leading technology companies over thirty years.
  • Shield Capital invests in early-stage venture capital companies building frontier technologies in artificial intelligence, autonomy, cybersecurity, and space.

Barmak Meftah Joins Open XDR Leader Stellar Cyber as Board Advisor

Retrieved on: 
Monday, August 22, 2022
Data Management, Security, Apps, Applications, Technology, Software, Networks, Internet, Stellar, SOAR, CEO, AT&T Cybersecurity, Fortify Software, Entrepreneurship, Hewlett-Packard, Meftah, Board, AT&T, Beckman Coulter, AT, Leadership, NDR, Director, General partnership, Marketing, SIEM, Weapon, Risk management, Oracle

Stellar Cyber, the innovator of Open XDR, today announced that Barmak Meftah has joined the company as an advisor to the Board of Directors.

Key Points: 
  • Stellar Cyber, the innovator of Open XDR, today announced that Barmak Meftah has joined the company as an advisor to the Board of Directors.
  • Today this vision has emerged as Open XDR, and Stellar Cyber is at the forefront of this accelerating trend.
  • Meftah draws on his extensive expertise as a leader in cybersecurity to help enhance Stellar Cybers product development and marketing strategies.
  • Our ability to attract a cybersecurity rock star like Barmak Meftah as an advisor to our Board is a testament to our vision and market leadership, said Changming Liu, CEO and Co-Founder and CEO of Stellar Cyber.

Bishop Fox Appoints VP of Product Management and VP of Engineering to Drive Product Innovation

Retrieved on: 
Thursday, April 14, 2022
Oracle Hyperion, Technology, HP, IPO, Woman, Culture, Twitter, Penelope, VP, KJ, Oracle, KUDO, GLOBE, New product development, Richard Foxe, LoopUp, Solution, Fortify Software, Hewlett-Packard, B2B, Product management, Linux, Senior, Linux Foundation, Management, Engineering, Opower, Cosmos, Cobalt, Software as a service

Yao is the tenth woman to join the Bishop Fox leadership team; nearly 50 percent of the companys leadership roles are filled by women.

Key Points: 
  • Yao is the tenth woman to join the Bishop Fox leadership team; nearly 50 percent of the companys leadership roles are filled by women.
  • We are excited to welcome Penny and KJ to our leadership team, said Vinnie Liu, Bishop Fox CEO.
  • Yao brings more than 15 years of experience in product management, product design, and consumer and enterprise consulting, with particular expertise in building high-performing product and design teams.
  • She comes to Bishop Fox from Cobalt Labs, a Pentesting-as-a-Service platform, where she was the Senior Director of Product Management.

Nudge Security raises $7 million in seed funding led by Ballistic Ventures to secure the modern workforce

Retrieved on: 
Tuesday, April 5, 2022
LinkedIn, Behavior, Organization, Russell, Lightspeed Venture Partners, Multimedia, AT&T, AT&T Cybersecurity, CISA, AT, CEO, CTO, Imperva, Intelligence, Fortify Software, Industry, Spitlers Edge, Twitter, VC, Blasco, Hewlett-Packard, Acquisition, Risk management, Cryptocurrency, Medical device, Weapon, Private investigator, Fortify, SIEM, Ballistics (disambiguation)

AUSTIN, Texas, April 5, 2022 /PRNewswire/ -- Nudge Security announced today $7 million in seed funding led by Ballistic Ventures, reuniting a team that has transformed the cybersecurity industry for over three decades. The investment marks the first to be announced by Ballistic, the new VC firm solely dedicated to advising and funding early-stage cybersecurity startups.

Key Points: 
  • Spitler and Blasco believe that modern cybersecurity is a battle over human behavior and defenders are losing ground.
  • "Nudge Security has a unique approach that will transform the human element of cybersecurity," said Roger Thornton of Ballistic.
  • Nudge Security founders and Ballistic partners have previously:
    Established the $12.9 billion application security market , founding Fortify Software in 2003.
  • Nudge Security is a cybersecurity startup securing modern organizations through the power of the modern workforce.

Independent, Head-to-Head Study Shows Significant Health Benefits of Early Fortification Associated with Prolacta Bioscience's 100% Human Milk-Based Fortifiers Compared to Cow Milk-Based Fortifiers for Premature Infants

Retrieved on: 
Tuesday, March 29, 2022
Method, Medicine, LinkedIn, NICU, Particle-size distribution, Clinical trial, Growth, Premature, Parent, Health maintenance organization, Lactoferrin, Part, FDA Adverse Event Reporting System, Antibody, Hospital, OMICS Publishing Group, Science, Health, Immunity, Food, Late preterm infant, Fortify Software, Jean-Louis Vincent, MD, Safety, Food and Drug Administration, Exclusive, Twitter, UHT, Infant, Milk, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Up Front, FDA, Instagram, Weight gain, Pasteurization, Nutritional science, Feed manufacturing, Health insurance, Nicu's Spoon Theater Company, Facebook

DUARTE, Calif., March 29, 2022 /PRNewswire/ -- An independent, head-to-head study from Neuburg, Germany, shows extremely low birth weight preterm infants fed Prolacta Bioscience® 100% human milk-based fortifiers (HMBF) as part of an Exclusive Human Milk Diet (EHMD) had reduced  incidences of life-threatening comorbidities and experienced shorter stays in the neonatal intensive care unit (NICU), compared to those fed cow/bovine milk-based fortifiers (CMBF), offsetting the higher therapeutic costs of HMBF.1 

Key Points: 
  • It found that preterm infants tolerate human milk-based fortifiers significantly better than bovine-based fortifiers, and while the human milk fortifiers entail higher therapeutic costs, they are offset by shorter in-hospital stays and fewer morbidities.
  • "15
    The major difference between cow milk-based and human milk-based products is the composition notably, the bioactive components that are unique to human milk.
  • is a privately held, global life sciences company dedicated to Advancing the Science of Human Milkto improve the health of critically ill, premature infants.
  • *Estimated number of premature infants fed Prolacta's products from January 2007 to December 2021; data on file.

Should Human Milk-Based Nutritional Products for Premature Infants Be Homogenized? More Research Is Needed, New Journal Article Says

Retrieved on: 
Wednesday, March 23, 2022
Method, LinkedIn, Growth, Milk, Digestion, Health maintenance organization, Lactoferrin, Research, FDA Adverse Event Reporting System, Current Developments in Nutrition, Antibody, MFG, Sphingolipid, Nutritional science, Health, Immunity, Food, Science, Fortify Software, Article, Safety, Twitter, UHT, Master of Science, Doctor of Philosophy, Infant, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, FDA, Instagram, Pasteurization, Impact, Dietary supplement, Vaccine, Facebook

DUARTE, Calif., March 23, 2022 /PRNewswire/ -- Prolacta Bioscience , the world's leading hospital provider of 100% human milk-based nutritional products for premature, critically ill infants, announced today the publication of a journal article that summarizes existing evidence on the impact of homogenization on human milk-based nutritional products.

Key Points: 
  • DUARTE, Calif., March 23, 2022 /PRNewswire/ -- Prolacta Bioscience , the world's leading hospital provider of 100% human milk-based nutritional products for premature, critically ill infants, announced today the publication of a journal article that summarizes existing evidence on the impact of homogenization on human milk-based nutritional products.
  • The implications of these changes for infant health are unknown," according to Reyes, scientific liaison, human milk and clinical research, at Prolacta.
  • The major difference between cow milk-based and human milk-based products is the composition notably, the bioactive components that are unique to human milk.
  • Prolacta's 100% human milk-based nutritional products have been evaluated in more than 20 clinical studies published in peer-reviewed journals.

Prolacta Bioscience Appoints Dr. Anne Beal to Board of Directors

Retrieved on: 
Monday, November 22, 2021
Premature, CEO, Professional degrees of public health, Annual general meeting, Industry, Brown University, Facebook, Biology, Columbia University Mailman School of Public Health, MD, Africa/Harvard School of Public Health Partnership for Cohort Research and Training, Health, Public, Faculty, GSK, Food and Drug Administration, Milk, Harvard School of Dental Medicine, Cornell University, Twitter, Patient-Centered Outcomes Research Institute, Lynn Elsenhans, Pasteurization, Columbia University, GlaxoSmithKline, Global health, Science, Instagram, Public health, Pediatrics, LinkedIn, Harvard Medical School, Fortify Software, Growth, Pharmaceutical industry

Beal joins the board with a wealth of experience and expertise in healthcare.

Key Points: 
  • Beal joins the board with a wealth of experience and expertise in healthcare.
  • Earlier in her career, Beal was a medical researcher and faculty member at both Harvard Medical School and the Harvard School of Public Health.
  • Prolacta Bioscience is making a lasting impact on the lives of babies and their families," Beal said.
  • Prolacta is headquartered in Duarte, California, and can be found online at www.prolacta.com , on Twitter , Instagram , Facebook and LinkedIn .